In the April/May issue of IP
Law & Business, we reported on the plight of Bob Shafer, a Stanford
University scientist embroiled in a dispute with Luxembourg-based
Advanced Biological Laboratories, S.A. (ABL). ABL claimed it owned two patents
that were being infringed by the world-renowned HIV-drug resistance database
Shafer created, HIVdb.
To recap quickly: After ABL
sent Stanford claim charts and a letter asserting its patent rights, Stanford
sued to invalidate the patents. That case settled, with Stanford agreeing to
post a notice on the database stating that users of HIVdb might infringe ABL's patents.
ABL subsequently sued Stanford,
saying the university had violated the settlement terms; the company also sued
Shafer for defamation, based largely on comments he posted on his website,
harmfulpatents.org. Shafer, tapping his own savings, hired attorneys at Day
Casebeer to file reexams on the two ABL patents. (Day Casebeer has since been
purchased by Howrey LLP.)
ABL's counterclaims against both Stanford and Shafer individually have now been settled. And it certainly appears that Chalom Sayada, the French doctor who is ABL’s CEO, has concerns about how the litigation makes him look to HIV researchers. The joint settlement statement reads, in part:
Continue reading "Patent Litigation Weekly: Stanford Researcher Loses at PTO, Still Fights On" »